113 related articles for article (PubMed ID: 15319247)
21. A pilot study of MVP (mitomycin-C, vinblastine and cisplatin) chemotherapy in small-cell lung cancer.
Hickish TF; Smith IE; Nicolson MC; Ashley S; Priest K; Spencer L; Norman A; Middleton G; O'Brien ME
Br J Cancer; 1998 Jun; 77(11):1966-70. PubMed ID: 9667676
[TBL] [Abstract][Full Text] [Related]
22. Combination chemotherapy with mitoxantrone, methotrexate, and mitomycin (MMM regimen) in malignant pleural mesothelioma: a phase II study.
Pinto C; Marino A; Guaraldi M; Melotti B; Piana E; Martoni A; Pannuti F
Am J Clin Oncol; 2001 Apr; 24(2):143-7. PubMed ID: 11319288
[TBL] [Abstract][Full Text] [Related]
23. Phase II study of first-line bortezomib and cisplatin in malignant pleural mesothelioma and prospective validation of progression free survival rate as a primary end-point for mesothelioma clinical trials (European Organisation for Research and Treatment of Cancer 08052).
O'Brien ME; Gaafar RM; Popat S; Grossi F; Price A; Talbot DC; Cufer T; Ottensmeier C; Danson S; Pallis A; Hasan B; Van Meerbeeck JP; Baas P
Eur J Cancer; 2013 Sep; 49(13):2815-22. PubMed ID: 23791541
[TBL] [Abstract][Full Text] [Related]
24. Aggressive multimodality therapy for malignant pleural mesothelioma.
Rice TW; Adelstein DJ; Kirby TJ; Saltarelli MG; Murthy SR; Van Kirk MA; Wiedemann HP; Weick JK
Ann Thorac Surg; 1994 Jul; 58(1):24-9. PubMed ID: 7518666
[TBL] [Abstract][Full Text] [Related]
25. A phase III trial of mitomycin C alone versus mitomycin C, vinblastine, and cisplatin for metastatic squamous cell lung carcinoma.
Veeder MH; Jett JR; Su JQ; Mailliard JA; Foley JF; Dalton RJ; Etzell PS; Marschke RF; Kardinal CG; Maksymiuk AW
Cancer; 1992 Nov; 70(9):2281-7. PubMed ID: 1394057
[TBL] [Abstract][Full Text] [Related]
26. Efficacy and safety of first- or second-line irinotecan, cisplatin, and mitomycin in mesothelioma.
Fennell DA; Steele JP; Shamash J; Evans MT; Wells P; Sheaff MT; Rudd RM; Stebbing J
Cancer; 2007 Jan; 109(1):93-9. PubMed ID: 17146783
[TBL] [Abstract][Full Text] [Related]
27. Survival of mesothelioma in a palliative medical care unit in egypt.
Ibrahim N; Abou-Elela E; Darwish D
Asian Pac J Cancer Prev; 2013; 14(2):739-42. PubMed ID: 23621229
[TBL] [Abstract][Full Text] [Related]
28. Platinum-based chemotherapy in metastatic breast cancer: the Leicester (U.K.) experience.
Decatris MP; Sundar S; O'Byrne KJ
Clin Oncol (R Coll Radiol); 2005 Jun; 17(4):249-57. PubMed ID: 15997920
[TBL] [Abstract][Full Text] [Related]
29. Cost-effectiveness of pemetrexed plus cisplatin: malignant pleural mesothelioma treatment in UK clinical practice.
Cordony A; Le Reun C; Smala A; Symanowski JT; Watkins J
Value Health; 2008; 11(1):4-12. PubMed ID: 18237355
[TBL] [Abstract][Full Text] [Related]
30. Cisplatin and vinorelbine first-line chemotherapy in non-resectable malignant pleural mesothelioma.
Sørensen JB; Frank H; Palshof T
Br J Cancer; 2008 Jul; 99(1):44-50. PubMed ID: 18542078
[TBL] [Abstract][Full Text] [Related]
31. A phase II study evaluating the cisplatin and epirubicin combination in patients with unresectable malignant pleural mesothelioma.
Berghmans T; Lafitte JJ; Paesmans M; Stach B; Berchier MC; Wackenier P; Lecomte J; Collon T; Mommen P; Sculier JP;
Lung Cancer; 2005 Oct; 50(1):75-82. PubMed ID: 16005104
[TBL] [Abstract][Full Text] [Related]
32. Treatment of malignant pleural mesothelioma with cisplatin, mitomycin C and alpha interferon.
Tansan S; Emri S; Selçuk T; Koç Y; Hesketh P; Heeren T; McCaffrey RP; Bariş YI
Oncology; 1994; 51(4):348-51. PubMed ID: 8208519
[TBL] [Abstract][Full Text] [Related]
33. Combined chemotherapy in pleurectomized malignant pleural mesothelioma patients.
Hastürk S; Tastepe I; Unlü M; Cetin G; Baris YI
J Chemother; 1996 Apr; 8(2):159-64. PubMed ID: 8708749
[TBL] [Abstract][Full Text] [Related]
34. Sequential chemotherapy with cisplatin/gemcitabine (CG) followed by mitoxantrone/methotrexate/mitomycin (MMM) in patients with malignant pleural mesothelioma. A multicenter Italian Phase II Study (SITMP1).
Pinto C; Marino A; De Pangher Manzini V; Benedetti G; Galetta D; Mazzanti P; Del Conte G; dell'Amore D; Piana E; Giaquinta S; Lopez M; Martoni A
Lung Cancer; 2006 May; 52(2):199-206. PubMed ID: 16542747
[TBL] [Abstract][Full Text] [Related]
35. Topotecan and pegylated liposomal doxorubicin combination as palliative treatment in patients with pretreated advanced malignant pleural mesothelioma.
Trafalis DT; Alifieris C; Krikelis D; Tzogkas N; Stathopoulos GP; Athanassiou AE; Sitaras NM
Int J Clin Pharmacol Ther; 2012 Jul; 50(7):490-9. PubMed ID: 22578202
[TBL] [Abstract][Full Text] [Related]
36. MVP (mitomycin-C, vinblastine, cisplatin) salvage chemotherapy for relapsed and refractory metastatic breast cancer.
Hsu C; Yeh KH; Hong RL; Yang CH; Lin MT; Chen YC; Cheng AL
J Formos Med Assoc; 1997 Mar; 96(3):185-8. PubMed ID: 9080756
[TBL] [Abstract][Full Text] [Related]
37. Vinorelbine plus cisplatin versus cisplatin plus vindesine and mitomycin C in stage IIIB-IV non-small cell lung carcinoma: a prospective randomized study.
Gebbia V; Galetta D; Riccardi F; Gridelli C; Durini E; Borsellino N; Gebbia N; Valdesi M; Caruso M; Valenza R; Pezzella G; Colucci G;
Lung Cancer; 2002 Aug; 37(2):179-87. PubMed ID: 12140141
[TBL] [Abstract][Full Text] [Related]
38. Short-term treatment-related symptoms and quality of life: results from an international randomized phase III study of cisplatin with or without raltitrexed in patients with malignant pleural mesothelioma: an EORTC Lung-Cancer Group and National Cancer Institute, Canada, Intergroup Study.
Bottomley A; Gaafar R; Manegold C; Burgers S; Coens C; Legrand C; Vincent M; Giaccone G; Van Meerbeeck J; ;
J Clin Oncol; 2006 Mar; 24(9):1435-42. PubMed ID: 16446322
[TBL] [Abstract][Full Text] [Related]
39. Is pleurectomy and decortication superior to palliative care in the treatment of malignant pleural mesothelioma?
Zahid I; Sharif S; Routledge T; Scarci M
Interact Cardiovasc Thorac Surg; 2011 May; 12(5):812-7. PubMed ID: 21345818
[TBL] [Abstract][Full Text] [Related]
40. The use of chemotherapy in patients with advanced malignant pleural mesothelioma: a systematic review and practice guideline.
Ellis P; Davies AM; Evans WK; Haynes AE; Lloyd NS;
J Thorac Oncol; 2006 Jul; 1(6):591-601. PubMed ID: 17409924
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
